Net profit of Gland Pharma rose 49.89% to Rs 215.48 crore in the quarter ended June 2025 as against Rs 143.76 crore during the previous quarter ended June 2024. Sales rose 7.41% to Rs 1505.62 crore in the quarter ended June 2025 as against Rs 1401.71 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 1505.62 | 1401.71 | 7 |
OPM % | 24.43 | 18.86 | - |
PBDT | 413.79 | 310.21 | 33 |
PBT | 312.74 | 218.25 | 43 |
NP | 215.48 | 143.76 | 50 |